KLAUSNER ARTHUR J - Insider Non-Derivative Transactions at Monopar Therapeutics (MNPR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 18, 2025, KLAUSNER ARTHUR J's relationship to Monopar Therapeutics (MNPR) is Director, and currently has 9,223 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MNPR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

KLAUSNER ARTHUR J - Insider Non-Derivative Transactions of MNPR Common Stock

KLAUSNER ARTHUR J - Insider Non-Derivative Transactions at MNPR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 19, 2025	Sell -- (Common Stock)	461	68.09	8762
Dec 19, 2025	Sell -- (Common Stock)	4660	67.06	9223
Dec 17, 2025	J -- (Common Stock)	7710	0	13883
Jan 1, 2024	M -- (Common Stock)	2533	0	30863
Oct 1, 2023	M -- (Common Stock)	2533	0	28330
Jul 1, 2023	M -- (Common Stock)	2534	0	25797
Apr 1, 2023	M -- (Common Stock)	2533	0	23263
Jan 1, 2023	M -- (Common Stock)	2859	0	20730